A
AVNS

AlphaQuest’s Avanos Medical AVNS Stock Holding History

AlphaQuest’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-50,147
Closed -$563K – 199
2025
Q4 		$563K Sell
50,147
-35,194
-41% -$403K 0.03% 735
2025
Q3 		$987K Buy
85,341
+48,250
+130% +$565K 0.06% 429
2025
Q2 		$454K Buy
37,091
+13,692
+59% +$172K 0.04% 645
2025
Q1 		$335K Buy
+23,399
New +$365K 0.04% 708
2024
Q3 		– Sell
-22,267
Closed -$444K – 1879
2024
Q2 		$444K Buy
+22,267
New +$434K 0.06% 496
2024
Q1 		– Sell
-14,589
Closed -$327K – 1650
2023
Q4 		$327K Buy
+14,589
New +$301K 0.07% 488

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

AlphaQuest's AVNS Position: Q1 2026 in Review

AlphaQuest sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 50,147 shares — an estimated $563K sold.

AlphaQuest first reported a position in AVNS in Q4 2023 and held it in 6 quarters. The position peaked at $987K in Q3 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • AlphaQuest reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 50,147 Avanos Medical shares in Q1 2026, an estimated $563K.
  • AlphaQuest first reported a position in Avanos Medical in Q4 2023 and held it in 6 quarters.
  • AlphaQuest's Avanos Medical position peaked at $987K in Q3 2025.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.